EQDC issues integrated hepatitis and high testing testing guidance



[ad_1]

The ECDC guidance advocates a concerted effort to remove integrated testing strategies or hepatitis B programs (HBV), hepatitis C (HCV) and HIV to reduce the large number of those who are now infected, but the anagens. Such integrated testing strategies or programs should appeal to the six core testing principles and respect the individual requirements of the tested:

  • Testing should be accessible, voluntary, confidential and contingent upon informed consent.
  • Appropriate information should be available before and after testing.
  • Linkage to Care is a critical part of an effective testing program.
  • Normalizing HPV, HQW and HIH testing in all healthcare settings; And
  • The carrying out of HIV, HBV and / or HCV testing should take appropriate training and education.
  • An effective national testing strategy, including a monitoring and development framework, is critical in responding to HPV, HCV and HIV infection.

The success in increasing the pharmacy testing should contribute significantly to the elimination of HIV and combat viral hepatitis as public health threat by 2030 as outlined in the sustainable development goals.

The ECDC guidance describes whom, where, how and when to test for viral hepatitis and HIV and offers options for testing strategies that apply to all healthcare settings and further (such as self-sampling and self-testing). Because of the higher infection infection, population groups suitable for HBV goals, HCV and / or HVEST testing include people who have sex with men, homeless people, sex workers, people who inject drugs, pregnant women or hemodialysis patients. The best project examples in the guidance provide opportunities for primary healthcare settings, hospitals, STI clinics, pharmacies, prisons and community settings, including drug and damage reduction services.

Integrated Testing: Health Benefits and "Synergies in Time of Middle Constraints"

"If we want to maximize the benefits of treatment for HIV or viral hepatitis, it is crucial to test and diagnose people as soon as possible in the course of infection, which is challenging as all three infections can typically be asymptomatic for years. According to ECDC estimates, it currently takes an average of three years from the time of HIV infection until diagnosis. That's way too long, "notes EkDC Director Andrea Amon. "Our new Testing Guidance offers a range of evidence-based options for the design of national or local testing interventions for different settings and populations at risk.A key of the key elements is to diversify and integrate testing services, as this allows for time-sensing devices Constraints.

Early diagnosis and linguaine care to bring strong individual and public health benefits: Effective HIV or viral hepatitis treatment or eliminates or suppresses the viruses significantly in turn means that those on treatment interrupt existing transmission chains, preventing further infections.

However, too many people who live with HIV or chronic hepatitis B or C in the EU. / Eyes are not aware of their infection – and so do not get treatment.

Venice AndroKeyaitis, the European Commissioner for Health and Food Safety, Said: "Advances in antiretroviral therapy have changed the nature of the HIV epidemic in Europe – HIV is no longer a fatal disease. For people who have been diagnosed early and have received effective treatment, HIV has become a chronic condition. In intensive testing efforts over the past decade, estimates show that one in seven of the living with HIV in the EU / Eee are still unyagnosed. We must focus our efforts on reaching people, and especially the most sensitive to G We must also intensify our efforts in testing for Hepatitis B and C, a disease estimated to affect 9 million people in the EU We need to adapt the three diseases together as we are to meet our sustainable development goal. Supporters of the European Testing Week. "

The European Testing Week starts today with more than 700 organizations in Europe and Central Asia promoting dialogue between those who can benefit from testing and those who offer tests – because early diagnoses of HIV and viral hypotension benefit everyone.

[ad_2]
Source link

EQDC issues integrated hepatitis and high testing testing guidance



[ad_1]

The ECDC guidance advocates a concerted effort to remove integrated testing strategies or hepatitis B programs (HBV), hepatitis C (HCV) and HIV to reduce the large number of those who are now infected, but the anagens. Such integrated testing strategies or programs should appeal to the six core testing principles and respect the individual requirements of the tested:

  • Testing should be accessible, voluntary, confidential and contingent upon informed consent.
  • Appropriate information should be available before and after testing.
  • Linkage to Care is a critical part of an effective testing program.
  • Normalizing HPV, HQW and HIH testing in all healthcare settings; And
  • The carrying out of HIV, HBV and / or HCV testing should take appropriate training and education.
  • An effective national testing strategy, including a monitoring and development framework, is critical in responding to HPV, HCV and HIV infection.

The success in increasing the pharmacy testing should contribute significantly to the elimination of HIV and combat viral hepatitis as public health threat by 2030 as outlined in the sustainable development goals.

The ECDC guidance describes whom, where, how and when to test for viral hepatitis and HIV and offers options for testing strategies that apply to all healthcare settings and further (such as self-sampling and self-testing). Because of the higher infection infection, population groups suitable for HBV goals, HCV and / or HVEST testing include people who have sex with men, homeless people, sex workers, people who inject drugs, pregnant women or hemodialysis patients. The best project examples in the guidance provide opportunities for primary healthcare settings, hospitals, STI clinics, pharmacies, prisons and community settings, including drug and damage reduction services.

Integrated Testing: Health Benefits and "Synergies in Time of Middle Constraints"

"If we want to maximize the benefits of treatment for HIV or viral hepatitis, it is crucial to test and diagnose people as soon as possible in the course of infection, which is challenging as all three infections can typically be asymptomatic for years. According to ECDC estimates, it currently takes an average of three years from the time of HIV infection until diagnosis. That's way too long, "notes EkDC Director Andrea Amon. "Our new Testing Guidance offers a range of evidence-based options for the design of national or local testing interventions for different settings and populations at risk.A key of the key elements is to diversify and integrate testing services, as this allows for time-sensing devices Constraints.

Early diagnosis and linguaine care to bring strong individual and public health benefits: Effective HIV or viral hepatitis treatment or eliminates or suppresses the viruses significantly in turn means that those on treatment interrupt existing transmission chains, preventing further infections.

However, too many people who live with HIV or chronic hepatitis B or C in the EU. / Eyes are not aware of their infection – and so do not get treatment.

Venice AndroKeyaitis, the European Commissioner for Health and Food Safety, Said: "Advances in antiretroviral therapy have changed the nature of the HIV epidemic in Europe – HIV is no longer a fatal disease. For people who have been diagnosed early and have received effective treatment, HIV has become a chronic condition. In intensive testing efforts over the past decade, estimates show that one in seven of the living with HIV in the EU / Eee are still unyagnosed. We must focus our efforts on reaching people, and especially the most sensitive to G We must also intensify our efforts in testing for Hepatitis B and C, a disease estimated to affect 9 million people in the EU We need to adapt the three diseases together as we are to meet our sustainable development goal. Supporters of the European Testing Week. "

The European Testing Week starts today with more than 700 organizations in Europe and Central Asia promoting dialogue between those who can benefit from testing and those who offer tests – because early diagnoses of HIV and viral hypotension benefit everyone.

[ad_2]
Source link